Michael Brands
- Molecular Medicine top 5%
- Organic Chemistry top 5%
- Synthesis and biological activity 5
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis 4
- Molecular Biology top 10%
- DNA Repair Mechanisms 5
- Ubiquitin and proteasome pathways 4
- Receptor Mechanisms and Signaling 4
- Microbiology top 5%
-
- Cancer-related Molecular Pathways 8
-
- Microtubule and mitosis dynamics 6
-
- Nitric Oxide and Endothelin Effects 3
- Co-authors
- Franz von NussbaumDieter HäbichStefan WeigandBerthold HinzenJohn E. HallKarl ZiegelbauerMagdalena Alonso‐GaliciaDion Zappe
- Journals
- Cancer Research (11 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Michael Brands
44 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Molecular Medicine 124
- Organic Chemistry 601
- Pharmacology 353
- Molecular Biology 1.1k
- Microbiology 86
Countries citing papers authored by Michael Brands
This map shows the geographic impact of Michael Brands's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Brands with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Brands more than expected).
Fields of papers citing papers by Michael Brands
This network shows the impact of papers produced by Michael Brands. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Brands. The network helps show where Michael Brands may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Brands, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2020 | 6 | |
| 3 | 2020 | 133 | |
| 4 | 2019 | 145 | |
| 5 | 2019 | 29 | |
| 6 | 2018 | 53 | |
| 7 | 2017 | 12 | |
| 8 | 2016 | 85 | |
| 9 | 2014 | 9 | |
| 10 | 2013 | 83 | |
| 11 | 2012 | 3 | |
| 12 | Antibacterial Natural Products in Medicinal Chemistry—Exodus or Revival?breakdown → | 2006 | 530 |
| 13 | 2005 | 15 | |
| 14 | 2005 | 5 | |
| 15 | 2005 | 8 | |
| 16 | 2004 | 168 | |
| 17 | 2003 | 58 | |
| 18 | 2003 | 28 | |
| 19 | 1994 | 23 | |
| 20 | 1989 | 5 |
About Michael Brands
Michael Brands is a scholar working on Molecular Medicine, Oncology, Molecular Biology, Cell Biology and Organic Chemistry, having authored 46 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), Microtubule and mitosis dynamics (6 papers), Synthesis and biological activity (5 papers), DNA Repair Mechanisms (5 papers), Microbial Natural Products and Biosynthesis (4 papers), Ubiquitin and proteasome pathways (4 papers), Receptor Mechanisms and Signaling (4 papers) and Nitric Oxide and Endothelin Effects (3 papers). The work is most often cited by research in Molecular Medicine (124 citations), Organic Chemistry (601 citations), Pharmacology (353 citations), Molecular Biology (1.1k citations) and Microbiology (86 citations). Michael Brands has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Franz von Nussbaum, Dieter Häbich, Stefan Weigand, Berthold Hinzen, John E. Hall, Karl Ziegelbauer, Magdalena Alonso‐Galicia, Dion Zappe, Lars Wortmann and Dominik Mumberg. Their work appears in journals such as Cancer Research, Bioorganic & Medicinal Chemistry Letters, Molecular Cancer Therapeutics, Tetrahedron and Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.